Founded in 2010, achieved ₹92 Cr first-year turnover, a record in Indian pharmaceutical history.
Introduced the first active-form folic acid formulation in India.
Developed a novel therapy for bone resorption by targeting elevated homocysteine levels.
Two product launches featured among the Top 20 new introductions in their first year.
Launched a female infertility treatment based on Nobel Prize-winning research.
Introduced an innovative approach for IVF treatment with Sildenafil Citrate in India.
Launched uterine fibroid management therapy using Ulipristal in India.
Introduced an advanced therapy for endometriosis treatment in India.
Introduced a new hypertension therapy in India.
Developed a new male infertility treatment concept in India.
Launched aqua-based, less painful progesterone injections in India.
Introduced Omega-3 fatty acid formulation for children’s cognitive health in India.
Pioneered Myo-inositol–based therapies offering comprehensive support for PCOS management.
1,500 employees joined in the first year, reflecting rapid organizational growth.
Reaching more than 1.5 lakh healthcare professionals every month.
Wide distribution network of over 1,200 stockists and 20 CFAs ensuring seamless delivery.
